GeoVax Labs, Inc. (GOVX) Stock Forecast
GOVX analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 2 analysts
- Price target
- $10.00 average of analyst targets
- Upside to target
- +4,096.4% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-1.02
- 52-week range
- $0.24 – $14.99
GOVX analyst ratings
2 analystsNumber of analysts at each rating.
GOVX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
GOVX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.09 | −$1.09 | −$1.09 | −$7.75 | +85.9% | 1 |
| Current fiscal year (2026) | −$5.14 | −$5.14 | −$5.14 | −$22.40 | +77.0% | 1 |
| Next fiscal year (2027) | −$2.85 | −$3.07 | −$2.64 | −$5.14 | +44.5% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
GOVX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 2 |
| Current fiscal year (2026) | $0 | $0 | $0 | −100.0% | 2 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
GOVX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
GOVX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$2.12 | −$2.12 | −$1.09 | −$1.09 | −$1.09 | −48.6% | 0 up · 1 down |
| Current fiscal year (2026) | −$8.70 | −$8.70 | −$5.14 | −$5.14 | −$5.14 | −40.9% | 0 up · 1 down |
| Next fiscal year (2027) | −$3.07 | −$3.07 | −$2.85 | −$2.85 | −$2.85 | −7.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
GOVX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; GOVX beat in 8 of 12.
What analysts expect from GOVX
2 analysts cover GeoVax Labs; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $10.00, 4,096.4% above the latest close of $0.24. Analysts expect earnings of −$5.14 per share for 2026, +77.0% from a year earlier. For 2027 the average estimate is −$2.85 per share. GeoVax Labs beat the EPS estimate in 8 of the last 12 quarters.
Related: GOVX income statement, GOVX key metrics, GOVX chart. See the GOVX stock overview for the latest quote and news.
GOVX forecast FAQ
What is GeoVax Labs's price target?
The average analyst price target for GeoVax Labs is $10.00, 4,096.4% above the latest close of $0.24.
Is GeoVax Labs a buy, hold or sell?
Of 2 analysts covering GeoVax Labs, 2 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is GeoVax Labs's EPS forecast?
Analysts forecast −$5.14 per share for 2026 (range −$5.14 to −$5.14); for 2027 the estimate is −$2.85.
When does GeoVax Labs report earnings?
GeoVax Labs is expected to report results for the quarter ending September 30, 2026 on November 12, 2026; the EPS estimate is $-1.02.
Does GeoVax Labs usually beat earnings estimates?
GeoVax Labs reported EPS at or above the analyst estimate in 8 of the last 12 quarters.